Biotech Investors & VC Firms
2475 firms in this list, with a median first check of $500K. 505 of them lead rounds. Generated from verified public data and updated continuously.
CapMan
HelsinkiGrowth–Late Stage$2.2M – $64.8M
19 people
Dimension Capital
San FranciscoSeed–Growth$1M – $10M
16 people
GS Futures
SeoulSeed–Series A
13 people
Lunar Ventures
BerlinPre-Seed–Seed$500K – $2M
15 people
MassVentures
WalthamPre-Seed–Seed$250K – $500K
9 people
SpringTide Ventures
BostonSeed–Series B$500K – $5M
15 people
Debiopharm Innovation Fund
LausannePre-Seed–Series A$1M – $5M
17 people
Taihill Venture
CambridgePre-Seed–Seed
11 people
Astellas Venture Management LLC
South San FranciscoSeed–Series C$200K – $5M
10 people
Qiming Venture Partners USA
CambridgeSeed–Series B
19 people
Unorthodox Ventures
AustinSeed–Growth$1M – $5M
16 people
Asset Management Company
Menlo ParkSeed–Series A$500K – $2M
6 people
Plum Alley Investments
New YorkSeed–Series A$500K – $1.5M
15 people
HealthQuest Capital
Redwood CityGrowth–Late Stage
14 people
Speciale Invest
ChennaiPre-Seed–Seed$1M
11 people
Ontario Centre of Innovation
TorontoPre-Seed–Seed$500K
19 people
Westlake Village BioPartners
Los AngelesPre-Seed–Series A$100K – $5M
13 people
Crescent Capital Partners
SydneyGrowth–Late Stage$13.2M – $52.8M
24 people
First Bight Ventures
HoustonSeed–Series A$1M – $2M
21 people
Xiang He Capital
BeijingSeed–Series B
3 people
SQN Venture Partners, LLC
CharlestonSeed–Growth
11 people
University of Cambridge Enterprise
CambridgePre-Seed–Seed
14 people
Omega Funds
BostonSeed–Late Stage
19 people
Deep Future
Seattle
3 people
Related lists
Investors & VC Firms in North America (12829)Investors & VC Firms in United States (11877)Investors & VC Firms in Europe (5831)Investors & VC Firms in Global (4737)AI & Machine Learning Investors & VC Firms (4564)Fintech Investors & VC Firms (4547)SaaS Investors & VC Firms (4223)Healthtech Investors & VC Firms (4191)Enterprise Software Investors & VC Firms (4100)Crypto & Web3 Investors & VC Firms (3974)
Data sourced from public filings and firms' own websites — see our methodology.




































































































